Sorafenib and TRC105 in Hepatocellular Cancer

Clinical trial NCT01306058 · COMPLETED

Trial details

NCT number: NCT01306058
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatoma Liver Neoplasms Adenoma, Liver Cell Carcinoma, Hepatocellular Liver Neoplasms, Experimental

Start date: 2011-02-11
Primary completion: 2016-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.